In neuroblastoma — a pediatric malignancy originating from neural crest–derived progenitor cells — neuroblasts fail to differentiate while transforming to a malignant cell state, often driven by aberrant high-level expression of MYCN or MYC (4, 5). This evidence concerns the gene MYCN and neuroblastoma.